Adenoid cystic carcinoma (ACC) is a rare, insidious malignancy, most commonly originating in the salivary glands, that presents unique diagnostic and therapeutic challenges. Recent decades have seen a ...
BUFFALO, NY – December 4, 2024 – A new editorial was published in Oncotarget’s Volume 15 on November 22, 2024, entitled “B7-H4: A potential therapeutic target in adenoid cystic carcinoma.” Researchers ...
RAS-mutated sporadic medullary thyroid cancer: A single-center experience. Recurrent or metastatic salivary gland tumor (MSGT) patients treated with selinexor, a first in class selective exportin-1 ...
Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation versus concurrent chemoradiotherapy with TPF in patients with locally advanced squamous ...
Rgenta Therapeutics Inc. has received IND clearance by the FDA for RGT-61159, which is being developed for adenoid cystic carcinoma, colorectal cancer and other solid tumors, as well as acute myeloid ...
The tonsils are lumps on each side at the back of the throat, whereas the adenoids are glands further up in the throat and behind the nose. They form part of the immune system. The tonsils and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results